BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for S Schierle

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.EBI
Goethe-University
Development and Profiling of Inverse Agonist Tools for the Neuroprotective Transcription Factor Nurr1.EBI
Goethe University Frankfurt
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics.EBI
Goethe-University Frankfurt
A New FXR Ligand Chemotype with Agonist/Antagonist Switch.EBI
Goethe-University Frankfurt
Design and Structural Optimization of Dual FXR/PPARδ Activators.EBI
Goethe University Frankfurt
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.EBI
Goethe University Frankfurt
A Selective Modulator of Peroxisome Proliferator-Activated Receptor γ with an Unprecedented Binding Mode.EBI
Goethe-University Frankfurt
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.EBI
Goethe-University Frankfurt
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.EBI
Goethe University Frankfurt
Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonists.EBI
Goethe-University Frankfurt